Verition Fund Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-22,394
| Closed | -$5.03M | – | 2445 |
|
|
2026
Q1 | $5.03M | Buy |
+22,394
| New | +$5.58M | 0.03% | 578 |
|
|
2025
Q4 | – | Sell |
-3,897
| Closed | -$1.07M | – | 3879 |
|
|
2025
Q3 | $1.07M | Sell |
3,897
-19,136
| -83% | -$5.23M | ﹤0.01% | 2489 |
|
|
2025
Q2 | $5.94M | Buy |
23,033
+5,617
| +32% | +$1.34M | 0.03% | 951 |
|
|
2025
Q1 | $3.9M | Buy |
17,416
+511
| +3% | +$119K | 0.02% | 1033 |
|
|
2024
Q4 | $3.87M | Buy |
16,905
+4,851
| +40% | +$1.17M | 0.02% | 1079 |
|
|
2024
Q3 | $2.94M | Buy |
12,054
+6,100
| +102% | +$1.36M | 0.01% | 1181 |
|
|
2024
Q2 | $1.14M | Buy |
5,954
+2,919
| +96% | +$592K | 0.01% | 1593 |
|
|
2024
Q1 | $601K | Buy |
3,035
+10
| +0.3% | +$1.83K | ﹤0.01% | 1914 |
|
|
2023
Q4 | $520K | Sell |
3,025
-968
| -24% | -$149K | ﹤0.01% | 1499 |
|
|
2023
Q3 | $590K | Buy |
3,993
+1,784
| +81% | +$323K | 0.01% | 1339 |
|
|
2023
Q2 | $483K | Sell |
2,209
-1,700
| -43% | -$379K | 0.01% | 1265 |
|
|
2023
Q1 | $856K | Buy |
3,909
+931
| +31% | +$202K | 0.01% | 1009 |
|
|
2022
Q4 | $620K | Buy |
2,978
+1,872
| +169% | +$411K | 0.01% | 1145 |
|
|
2022
Q3 | $241K | Buy |
+1,106
| New | +$252K | ﹤0.01% | 2382 |
|
|
2022
Q2 | – | Sell |
-1,343
| Closed | -$326K | – | 2944 |
|
|
2022
Q1 | $326K | Buy |
+1,343
| New | +$325K | ﹤0.01% | 2115 |
|
|
2021
Q4 | – | Sell |
-1,284
| Closed | -$338K | – | 2767 |
|
|
2021
Q3 | $338K | Buy |
+1,284
| New | +$351K | ﹤0.01% | 1419 |
|
|
2021
Q2 | – | Sell |
-1,077
| Closed | -$226K | – | 2100 |
|
|
2021
Q1 | $209K | Buy |
+1,077
| New | +$216K | ﹤0.01% | 1322 |
|
|
2020
Q4 | – | Sell |
-3,555
| Closed | -$609K | – | 1353 |
|
|
2020
Q3 | $609K | Buy |
+3,555
| New | +$656K | 0.01% | 507 |
|
|
2020
Q2 | – | Sell |
-17,695
| Closed | -$2.61M | – | 1148 |
|
|
2020
Q1 | $2.61M | Buy |
+17,695
| New | +$2.82M | 0.1% | 133 |
|
|
2018
Q4 | – | Sell |
-2,611
| Closed | -$301K | – | 1180 |
|
|
2018
Q3 | $301K | Sell |
2,611
-6,358
| -71% | -$696K | 0.01% | 1030 |
|
|
2018
Q2 | $929K | Buy |
+8,969
| New | +$908K | 0.06% | 437 |
|
|
2017
Q4 | – | Sell |
-2,703
| Closed | -$208K | – | 1177 |
|
|
2017
Q3 | $208K | Buy |
+2,703
| New | +$207K | 0.02% | 1053 |
|
|
2017
Q2 | – | Sell |
-3,017
| Closed | -$217K | – | 1233 |
|
|
2017
Q1 | $217K | Buy |
+3,017
| New | +$208K | 0.02% | 1003 |
|
|
2016
Q4 | – | Sell |
-12,040
| Closed | -$780K | – | 1375 |
|
|
2016
Q3 | $780K | Buy |
+12,040
| New | +$801K | 0.08% | 293 |
|
|
2016
Q2 | – | Sell |
-4,621
| Closed | -$267K | – | 1022 |
|
|
2016
Q1 | $267K | Sell |
4,621
-15,948
| -78% | -$903K | 0.04% | 522 |
|
|
2015
Q4 | $1.1M | Buy |
+20,569
| New | +$1.16M | 0.21% | 93 |
|
|
2015
Q2 | – | Sell |
-6,004
| Closed | -$431K | – | 703 |
|
|
2015
Q1 | $431K | Buy |
+6,004
| New | +$390K | 0.05% | 128 |
|
|
2013
Q3 | – | Sell |
-5,406
| Closed | -$244K | – | 671 |
|
|
2013
Q2 | $244K | Buy |
+5,406
| New | +$256K | 0.04% | 425 |
|
Other funds holding RMD
Verition Fund Management's RMD Position: Q2 2026 in Review
Verition Fund Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 22,394 shares — an estimated $5.03M sold.
Verition Fund Management first reported a position in RMD in Q2 2013 and held it in 28 quarters. The position peaked at $5.94M in Q2 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Verition Fund Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Verition Fund Management sold 22,394 ResMed shares in Q2 2026, an estimated $5.03M.
- Verition Fund Management first reported a position in ResMed in Q2 2013 and held it in 28 quarters.
- Verition Fund Management's ResMed position peaked at $5.94M in Q2 2025.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.